CA19–9 Decrease and Survival According to Platelet Level in Patients With Advanced Pancreatic Cancer

BMC Cancer - United Kingdom
doi 10.1186/s12885-019-6078-2
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Sustained CA19-9 Response to Neoadjuvant Chemotherapy in Borderline Resectable Pancreatic Cancer Predicts Progression and Survival

Oncologist
Cancer ResearchMedicineOncology
2020English

Elevated CEA and CA19-9 Serum Levels Independently Predict Advanced Pancreatic Cancer at Diagnosis

Biomarkers
MutagenesisClinical BiochemistryBiochemistryHealthMedicineToxicology
2020English

Elevated Baseline CA19-9 Levels Correlate With Adverse Prognosis in Patients With Early- Or Advanced-Stage Pancreas Cancer

Medical Oncology
MedicineCancer ResearchOncologyHematology
2012English

Mean Platelet Volume Predicts Survival in Pancreatic Cancer Patients With Synchronous Liver Metastases

Scientific Reports
Multidisciplinary
2018English

A Case of Pancreatic Cancer With False‐positive CA19‐9 Result Due to Hyperglycemia Six Years After Pancreaticoduodenectomy

The Japanese Journal of SURGICAL METABOLISM and NUTRITION
2019English

A Case of the Lung Cancer Presented With Abnormally High Serum Ca19-9 Level

The journal of the Japanese Practical Surgeon Society
1990English

Extended RAS Analysis and Correlation With Overall Survival in Advanced Pancreatic Cancer

British Journal of Cancer
Cancer ResearchOncology
2017English

Investigation of Unexpected Serum CA19-9 Elevation in Lewis-Negative Cancer Patients

Annals of Clinical Biochemistry
MedicineClinical Biochemistry
2012English

Failure of Normalization of CA19-9 Following Resection for Pancreatic Cancer Is Tantamount to Metastatic Disease

Annals of Surgical Oncology
OncologySurgery
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy